- May 2017 - October 2018
- Cristina Villanueva Belmonte (ISGlobal)
- Funded by
- Human Genetics Foundation (Turin, Italy) and EC project EXPOSOMICS
Lack of access to improved drinking water sources is still a main problem in many parts of the world, leading to high incidence rates of waterborne infections or sanitation-related diseases.
Chlorination of drinking water is a major public health intervention to provide safe drinking water to the population and control for water-borne infectious diseases. On the other hand, disinfection process with chlorine generates undesired chemical by-products such as trihalomethanes (THMs). In some countries, this environmental exposure can be of concern since the whole population is exposed through ingestion, inhalation and dermal contact, and long-term exposure to THMs has been linked to disease, including bladder cancer.
THM levels in drinking water are regulated in many countries worldwide but are rarely reported in the majority of them and current levels at a global scale are unknown.
- To develop a global map of current THM levels in drinking water (total and chloroform, bromoform, dibromochloromethane, bromodichloromethane)
- To estimate bladder cancer burden attributable to THM levels at a global scale
- To conduct a comparative risk assessment between bladder cancer attributable to THM levels and water-borne infectious diseases attributed to lack of improved drinking water sources.
In 2016, we conducted the same study for Europe and we are now expanding it to include non-European countries.
The project is led by Dr Cristina Villanueva together with Prof Manolis Kogevinas, Dr Susan Richardson (University of South Carolina) and Dr Stuart Krasner (Metropolitan Water District of Southern California) in the US and is coordinated by Dr Iro Evlampidou. Other close collaborators in the project are Weidong Qu (School of Public Health, Shanghai, China and David Reckhow (University of Massachusetts, US).
This project will provide for the first time a global assessment of current levels of THMs that, surprisingly, do not exist. THM exposure estimates will allow the development of disease risk assessment at a global scale.
Current status of the project
Open Call for collaborators!
We are looking for collaborators in many countries in the world to provide THM data (total and chloroform, bromoform, dibromochloromethane, bromodichloromethane) (see map below).
Click the following links to see the study protocol and the questionnaire.
If you are interested please contact us at email@example.com
Many thanks to the people who have contributed data or helped us connect with the people who have the data we need!
Other projectsSee Past Projects
Population based multicasecontrol study on common tumours in Spain
Ageing Lungs in European Cohorts
Physical Activity as a Crucial Patient Reported Outcome in COPD
Network on the Coordination and Harmonisation of European Occupational Cohorts
Impact Of Pollution on Asthma and Rhinitis
Exposome Project for Health and Occupational Research
Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors
Leveraging the European Genome-Phenome Archive (EGA) for Industry and Society
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Cohorte Covid-19 en Cataluña
Signs of Early Adaptation to Climate Change
Exposure to emerging contaminants in drinking water in Barcelona potentially liked to chronic diseases and wellbeing
Las Voces de los Afectados por la Nefropatía Mesoamericana
Co-created educational programme for dyspnea-bearing patients and their caregivers
Risk of colorectal and breast cancer with widespread drinking water chemical contaminants
Cohort of COVID-19 in Spain: social dynamics, mental health and inequalities
EXposome Powered tools for healthy living in urbAN SEttings
Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia
¿Es mejor consumir el agua de grifo si queremos reducir la exposición a nano/micropláticos?
Characterization of Oral NMP Exposure
In-Depth Genomics and Cross-Omics Analysis for Undiagnosed Rare Diseases on a User-Friendly Collaborative Platform